AG0039KY

184475-35-2 | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine

AG0039KY

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	184475-35-2
Catalog Number	AG0039KY(AGN-PC-0QDC4B)
Chemical Name	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
IUPAC Name	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
InChI	InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
InChI Key	XGALLCVXEZPNRQ-UHFFFAOYSA-N
MDL Number	MFCD04307832
Molecular Formula	C22H24ClFN4O3
Molecular Weight	446.9024
SMILES	ClC=1C=C(C=CC1F)NC1=NC=NC2=CC(=C(C=C12)OCCCN1CCOCC1)OC
UNII	S65743JHBS
Synonyms	gefitinib, Iressa, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide, ZD 1839, ZD1839, Gefitinib, 184475-35-2, Iressa, ZD1839, Irressat, gefitinib (zd1839), N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, ZD 1839, ZD-1839, N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine, UNII-S65743JHBS, CCRIS 9011, CHEMBL939, 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine, S65743JHBS, CHEBI:49668, XGALLCVXEZPNRQ-UHFFFAOYSA-N, MFCD04307832, 3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine, NCGC00159455-02, AK-72948, 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-, DSSTox_CID_21034, DSSTox_RID_79614, DSSTox_GSID_41034, Gefitinib [USAN], Q-201149, Gefitinib; Iressa, 4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline, N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, Iressa(TM), IRE, Iressa (TN), CAS-184475-35-2, SR-00000000262, gefitinibum, Gefitinib (JAN/USAN/INN), Gefitinib [USAN:INN:BAN], Gefitinib;, Gefitini; Iressa, 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-, gefitinib (iressa), Gefitinib - Iressa, IRRESSA, Iressa (AstraZeneca), nchembio866-comp14, Kinome_3321, Kinome_3322, Iressa|||ZD 1839, AC1L3X0A, SCHEMBL7866, Gefitinib,ZD-1839,Iressa, Gefitinib/ZD-1839,Iressa, KBioSS_002241, MLS003899193, CU-00000000396-1, Gefitinib, Iressa, ZD1839, BDBM5447, cid_123631, EBD446, GTPL4941, DTXSID8041034, Gefitinib, >=98% (HPLC), CTK7A0364, AOB6917, QCR-105, SYN1042, BCPP000221, HMS2089B19, HMS3244M21, HMS3244M22, HMS3244N21, HMS3654A07, HMS3677H08, HMS3714A05, Pharmakon1600-01502274, AMX10169, BCP01365, Tox21_111683, ABP000855, CG0031, FC0028, GP9843, NSC715055, NSC759856, RS0033, s1025, STK621310, ZINC19632614, AKOS000280752, Tox21_111683_1, AB20814, AC-1556, AN-5192, API0002810, BCP9000718, CCG-220642, CS-0124, DB00317, KS-1204, MCULE-6951584187, NSC-715055, NSC-759856, 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine, KS-00000E11, NCGC00159455-03, NCGC00159455-04, NCGC00159455-05, NCGC00159455-06, NCGC00159455-08, NCGC00159455-09, NCGC00159455-14, 4CA-0562, AJ-74091, BC215794, BCB03_000781, BR-72948, CC-28943, CJ-16232, EN002708, H018, HY-50895, SC-18023, SMR002204119, SY002154, AB0000095, LS-139916, ST2413546, AM20090619, FT-0081035, FT-0602325, SW199108-4, EC-000.2409, MFCD04307832 (98%), D01977, G-4408, J10250, K00240, S-2176, 15215-EP2269994A1, 15215-EP2272827A1, 15215-EP2272832A1, 15215-EP2275413A1, 15215-EP2277865A1, 15215-EP2280006A1, 15215-EP2281813A1, 15215-EP2281815A1, 15215-EP2287156A1, 15215-EP2292234A1, 15215-EP2292615A1, 15215-EP2298768A1, 15215-EP2298778A1, 15215-EP2301533A1, 15215-EP2301933A1, 15215-EP2305640A2, 15215-EP2305671A1, 15215-EP2311807A1, 15215-EP2311827A1, 15215-EP2311840A1, 15215-EP2316832A1, 15215-EP2316833A1, 32333-EP2281815A1, 32333-EP2292615A1, 32333-EP2301933A1, 32333-EP2305640A2, 32333-EP2305671A1, 32333-EP2311827A1, AB01273954-01, AB01273954-02, AB01273954-03, AB01273954_04, 475G352, A812870, C-22438, I01-1227, SR-00000000262-2, SR-00000000262-3, Gefitinib, EuropePharmacopoeia (EP) Reference Standard, Z1551429741, (3-chloro-4-fluorophenyl)[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine, 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)-quinazoline, 4-(3-CHLORO-4-FLUOROANILINO)-7-METHOXY-6-(3-MORPHOLINOPROPOXY)QUINAZOLINE, 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-, Gefitinib for system suitability, EuropePharmacopoeia (EP) Reference Standard, N-(3-chloranyl-4-fluoranyl-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine, (3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE, Gefitini, Tarceva, Iressa/Gefitinib, C22H24ClFN4O3, D09XZB, Gefitinib,Iressa, ZD1839, cc-596, Tyrosine Kinase Inhibitor - Ns, ZD-1839, Iressa, Gefitinib, Gefitinib, 99% - 1MG 1mg, C22-H24-Cl-F-N4-O3, CID123631, ACN-032362, CS-O-11657, A8219, A10422, C419708, D000077156, 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide, na,

Complexity	545
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	446.152g/mol
Formal Charge	0
Heavy Atom Count	31
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	446.907g/mol
Monoisotopic Mass	446.152g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	68.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H332-H335
Packing Group
Precautionary statements	P261-P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number